Emamectin B 2a Application of its salt compounds

By modifying the structure of avermectin B2a to prepare methylaminoavermectin B2a and its salt compounds, the problem of wasted avermectin B2 components was solved, achieving highly efficient control of root-knot nematodes and improving efficacy and stability.

CN115624031BActive Publication Date: 2024-11-26HEBEI VEYONG BIO CHEM
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202211263136.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-14
Publication Date
2024-11-26
Estimated Expiration
2042-10-14

AI Technical Summary

Technical Problem

In existing technologies, a large amount of abamectin B2 components are left unused or discarded, resulting in waste. Furthermore, existing pesticides and biocontrol bacteria have limited efficacy against root-knot nematodes and are prone to resistance and pesticide residue issues.

Method used

By modifying the structure of abamectin B2a, methylaminoavermectin B2a and its salt compounds were prepared, improving their solubility and stability, and used to prepare insecticides for controlling plant root-knot nematodes.

Benefits of technology

It improves efficacy, extends the duration of efficacy, and enhances permeability to the cell membranes of target pests, providing a new method for controlling plant root-knot nematodes.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115624031B_ABST
    Figure CN115624031B_ABST
Patent Text Reader

Abstract

The invention discloses an avermectin B 2a Salt compounds and applications thereof, belonging to the technical field of agricultural chemicals and their preparation, avermectin B 2a The structure of the salt compound is shown in Figure I: #imgabs0# where X ‑ is an acid anion, the emamectin B 2a The present invention prepares avermectin B 2a And a series of avermectin B 2a Salt compounds, through a large number of efficacy experiments found that avermectin B 2a Its salt can be used for the prevention and treatment of plant root-knot nematodes, and has a good control effect. It is Avermectin B 2a The application of
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of agricultural chemicals and their preparation, and relates to an avermectin B 2a and its salts, and application of the compounds in the field of plant nematode control. Background Art

[0002] Nematodes can cause serious damage to agriculture, forestry, and animal husbandry. It is estimated that they cause losses equivalent to US$100 billion to global crops every year. Root-knot nematodes (Meloidogyne sp.) are nematodes that seriously damage many important crops and are widely distributed in vegetables, fruit trees, grain crops, etc. Therefore, research on biological control of nematodes has received much attention. So far, more than 100 species of root-knot nematodes have been reported worldwide, and about 40 species have been reported in China. At present, the prevention and control of root-knot nematode diseases mainly adopts single pesticides, biocontrol bacteria, and soil fumigants. Chemical agents include chloranthate granules, miler granules, chloranthate granules, methyl isoflavone emulsifiable concentrate, fluopyram suspension, etc. Biocontrol bacteria include Verticillium chlamydosporium, Paecilomyces lilacinus, Serratia marcescens, Bacillus subtilis, etc. Soil fumigants include chloropicrin, dazomet, pyram, sulfuryl fluoride, etc., which can effectively reduce the damage of root-knot nematode disease. However, pesticides and soil fumigants have pesticide residue problems, biocontrol bacteria have a short effective action time, and root-knot nematodes have increased their resistance to them year by year. Recently, there have been many reports that emamectin benzoate has a good effect on nematode prevention, but emamectin benzoate is relatively rarely used for nematode prevention in the market, and its application in the prevention and control of root-knot nematodes is even rarer. Through field investigations, it is found that the application technology is still not perfect.

[0003] Avermectin is produced by Sterptomyces avermitills. It is a type of streptomycin and belongs to the gray streptomycin. Avermectin is a mixture of fermentation components, with a total of 8 components: A1a, A 1b , A 2a , A 2b , B 1a , B 1b , B 2a , B 2b Among them, the activity of avermectin B1 is much higher than that of avermectin B2. Therefore, the commercialized avermectin technical on the market currently refers to avermectin B1 (B 1a ≥ 96%, B 1b ≤4%). After extracting avermectin B1 from the fermentation broth, it contains more than 20% avermectin B 2a , B 2b A large amount of avermectin B2 will be shelved or discarded, causing huge waste. Therefore, it is very necessary to study and apply the avermectin B2 component. Summary of the invention

[0004] The purpose of the present invention is to provide avermectin B 2a The application of its salt compounds. Make full use of the substances in the avermectin fermentation broth.

[0005] To achieve the above purpose, the technical solution adopted by the present invention is as follows:

[0006] Emamectin B 2a The salt compound has a structure as shown in Formula I:

[0007]

[0008] Where X - It is an acid anion.

[0009] Furthermore, the acid includes a mixture of one or more of formic acid, benzoic acid, methanesulfonic acid, sorbic acid, caprylic acid, gluconic acid, maleic acid, fumaric acid, tartaric acid, malonic acid, and citric acid.

[0010] Emamectin B 2a The preparation method of the salt compound comprises the following steps:

[0011] A. Avermectin B 2a The hydroxyl group at position 5 is protected by using a hydroxyl protecting group in an inert solvent at low temperature as a raw material;

[0012] B. Continue to carry out oxidation reaction of 4" hydroxyl group in the reaction solution of step A above, add acyl chloride to carry out oxidation reaction in the presence of DMSO and organic base, and oxidize 4" hydroxyl group to ketone;

[0013] C. The oxidation product is subjected to an amination reduction reaction, reacted with heptamethyldisilazane or methylamine in the presence of a catalyst, and then methanol is added to reduce the reaction with sodium borohydride to obtain an amination product;

[0014] D. Add palladium chloride to the reaction solution of step C, and continue to add sodium borohydride to remove the 5-hydroxyl protecting group to obtain avermectin B 2a ;

[0015]

[0016] E. Add avermectin B in the solvent 2a After dissolving and clarifying, add the corresponding acid, control the temperature below 40°C, stir for 30 minutes, and concentrate under reduced pressure to obtain the corresponding avermectin B 2a Salt.

[0017] The dosage of formic acid, benzoic acid, methanesulfonic acid, caprylic acid, sorbic acid and emamectin B2a The molar ratio is 1:1; the amount of gluconic acid, maleic acid, fumaric acid, tartaric acid, malonic acid, and citric acid is the same as that of avermectin B 2a The molar ratio is 0.5:1.

[0018] The inert solvent in step A is any one of dichloromethane, dichloroethane, and toluene; the hydroxyl protecting group is any one of allyl chloroformate and trimethylsilyl chloride; the solution for the amination reduction reaction in step C is butyl acetate or isopropyl acetate solution, and the catalyst is any one of zinc chloride, zinc acetate, and zinc trifluoroacetate.

[0019] Preferably, the solvent in step E is selected from methanol, ethanol, dichloromethane, dichloroethane, sec-butyl acetate, and isopropyl acetate.

[0020] Preferably, the amount of solvent used in step E is about the same as that of avermectin B 2a The weight ratio is 4:1 to 10:1.

[0021] Emamectin B 2a The application of the compound and its salt compounds is used for the prevention and treatment of plant root-knot nematodes.

[0022] Emamectin B 2a The application of the salt compounds thereof is used for preparing insecticides for preventing and controlling plant root-knot nematodes.

[0023] Due to the adoption of the above technical solution, the effects achieved by the present invention are as follows:

[0024] The present invention improves the performance of avermectin B by forming salts with different acids. 2a The solubility of avermectin B was obtained. 2a And a series of avermectin B 2a salt compounds and discovered avermectin B 2a Its salts can be used for the prevention and treatment of plant root-knot nematodes, and the permeability of the target pest cell membrane improves the efficacy. At the same time, the salt formation with different acids also improves the 2a Stability, greatly extending the efficacy period, and has a good prevention and control effect, for Avermectin B 2a The application of DETAILED DESCRIPTION

[0025] The present invention is described in detail below by way of examples, but the protection scope of the present invention is not limited to the following examples.

[0026] Example 1 4"-deoxy-4"-methylamino avermectin B 2a Preparation

[0027] 100g (0.11mol) avermectin B 2a (Content B 2a 98%) was dissolved in 500mL of dichloromethane, cooled to -25°C, 14.5g (0.12mol) of allyl chloroformate and 13.9g (0.12mol) of tetramethylethylenediamine were slowly added dropwise, and the reaction was carried out for 2 hours. The temperature was raised to -10°C, 13.8g (0.12mol) of tetramethylethylenediamine and 22g (0.54mol) of dimethyl sulfoxide were added, and 20.2g (0.068mol) of solid phosgene dissolved in 50g of dichloromethane were slowly added dropwise, and the reaction was carried out for 3 hours. 5% phosphoric acid solution was added to adjust the pH value to 2, and then 10% sodium hydroxide solution was used to adjust the pH value to 7-8, the layers were separated, the organic phase was dried with sodium sulfate, and the solvent was removed under reduced pressure to obtain the oxide.

[0028] Dissolve the oxide in 800ml isopropyl acetate, add 22.7g (0.13mol) heptamethyldisilazane and 1.0g zinc chloride, and keep warm at 75℃ for 6 hours. Start cooling, add 20g methanol, and when the temperature drops to 0℃, add 4.2g (0.11mol) sodium borohydride, and keep for 1 hour. Add 10g methanol, 0.005g palladium tetrachloride, 4.2g (0.11mol) sodium borohydride, and react at 0-5℃ for 2 hours. Terminate the reaction with 10% phosphoric acid solution, adjust the pH to 2-3, and then adjust the pH to 7-8 with 10% sodium carbonate solution, and separate the layers. Extract the aqueous phase twice with 20g isopropyl acetate, combine the organic phases, and obtain avermectin B 2a Isopropyl acetate solution. Concentrate under reduced pressure to obtain avermectin B 2a 90.3g, content 95%.

[0029] lH NMR (CDCl3, 500Hz) σ: 6.07 (m, lH), 5.96 (m, 1H), 5.75 (m, lH), 5.55-5.40 (m, 3H), 5.20 (m, lH), 4.90 (m, lH), 4.83 (m, 2H), 4.55 (br d,J=9.1,lH),4.33(m,lH),4.18(m,lH),4.04(br s,lH),3.98(m,2H),3.89(m,lH),3.84(m,lH),3.77(m, lH),3.70(m,lH),3.66(s,3H),3.60(s,3H),3.53(m,2H),3.48(m,lH),3.07(m,lH), 2.88(s,3H,N-Me),2.77(m,lH),2.56-2.35(m,3H),2.31(dd,J1=15.5,J2=5.0,lH), 2.19-2.00(m,2H),1.96(brs,4H),1.95(m,2H),1.88(m,lH),1.83-1.56(om,6H),1.50(br s, 3H), 1.44 (d, J = 7.7, 3H), 1.35 (d, J = 8.2, 3H), 1.20 (d, J = 9.0, 3H), 0.86 (m, 10H).

[0030] LC-MS [M+H] + :905, Emamectin B 2a M+H calculated value: 905

[0031] Example 2 Avermectin B 2a Preparation of benzoate

[0032] Take 90g (0.095mol) of 95% avermectin B 2a , dissolve in 360g of dichloromethane, add 11.8g of 98.0% benzoic acid, stir at room temperature for 0.5h, then heat and distill under reduced pressure to obtain a white solid, which is avermectin B 2a Benzoate, content is 95.0%.

[0033] Example 3 Emamectin B 2a Preparation of tartrate

[0034] Take 90g (0.095mol) of 95% avermectin B 2a , dissolve it in 900g methanol, add 7.2g DL tartaric acid with a content of 98.0%, stir at room temperature for 0.5h, then heat up and distill under reduced pressure to obtain a white solid, which is: Emamectin B 2aBenzoate, content is 95.4%.

[0035] Example 4 Emamectin B 2a Preparation of gluconate

[0036] Take 90g (0.095mol) of 95% avermectin B 2a , dissolve in 500g of sec-butyl acetate, add 9.35g of D-gluconic acid, stir at room temperature for 0.5h, then heat and distill under reduced pressure to obtain a white solid, namely avermectin B 2a Gluconate, content is 94.4%.

[0037] Example 5 Emamectin B 2a Formate, Emamectin B 2a Methanesulfonate, Emamectin B 2a Sorbate, Emamectin B 2a Caprylate, Emamectin B 2a Maleate, Emamectin B 2a Fumarate, Emamectin B 2a Malonate, Emamectin B 2a Preparation of citrate

[0038] The preparation method used in this example is the same as that in Example 2, except that benzoic acid is replaced with corresponding formic acid, methanesulfonic acid, sorbic acid, caprylic acid, maleic acid, fumaric acid, malonic acid, and citric acid, and the amount of each acid is adjusted accordingly.

[0039] Drug efficacy experiment

[0040] The test was conducted in accordance with NY / T 1833.1-2009 “Guidelines for Indoor Bioassay Tests of Pesticides - Nematicides” Part 1: Insect immersion method for inhibition of plant pathogenic nematodes.

[0041] 1. Test material preparation

[0042] The southern root-knot nematodes used in the experiment were cultured on tomatoes and kept ready for use in the egg stage.

[0043] 2. Test agents and initial screening concentrations

[0044] Test agent: Emamectin B 2a , Emamectin B 2a Formate, Emamectin B 2a Benzoate, Emamectin B 2a Methanesulfonate, Emamectin B 2a Sorbate, Emamectin B 2a Caprylate, Emamectin B2a Gluconate, Emamectin B 2a Maleate, Emamectin B 2a Fumarate, Emamectin B 2a Malonate, Emamectin B 2a Tartrate, Emamectin B 2a A total of 12 citrate compounds were provided by Hebei Weiyuan Biochemical Co., Ltd.;

[0045] The control drugs were avermectin, fluopyram, and thiathion.

[0046] Reference southern root-knot nematode resistance to fluopyram, thiazolin and avermectin concentrations of 0.2 mg / L, 0.5 mg / L and 1.0 mg / L.

[0047] 3. Preparation of Nematode Suspension

[0048] Fresh plant roots infected with root-knot nematodes were cleaned, cut into 1 cm long segments, put into a tissue crusher with 3 times the amount of water and crushed for 30 seconds, transferred to a combination of 200 mesh (pore size 75 μm) and 500 mesh (pore size 26 μm) standard sieves, and the plant tissues in the sieves were rinsed with tap water. The nematode eggs in the 500-mesh standard sieve were collected and surface disinfected with a 0.5% NaClO solution for 3 minutes. After rinsing with sterile water for 5 times, they were placed in a homemade Behman funnel and cultured in a dark incubator at 25°C. The southern root-knot nematode J2 was collected every 24 hours for later use.

[0049] 4. Chemical treatment

[0050] According to the experimental design, the above test agents were gradiently diluted with 0.1% Triton aqueous solution, and 0.1% Triton aqueous solution was used as a control. The collected root-knot nematodes J2 hatched within 24 hours were made into a suspension (about 200 / mL) with clean water. 0.5mL of the drug solution and 0.5mL of the J2 suspension were transferred into a 24-well plate with a pipette. The plate was repeated 3 times. After mixing with a thin glass rod, the plate was placed in a constant temperature incubator at 25°C for incubation in the dark. The total number of J2 insects and the number of dead insects were checked after 24 h, 48 h, and 72 h, and the mortality rate and corrected mortality rate were calculated.

[0051] 5. Check the results

[0052] The nematode death was determined by needle pricking under a stereo microscope, the number of dead nematodes was counted, and the nematode mortality rate and corrected mortality rate were calculated using the following formula:

[0053] Mortality (%) = number of dead nematodes / number of treated nematodes × 100%

[0054] Corrected mortality rate (%) = (treatment mortality rate - control mortality rate) / (100 - control mortality rate) × 100%

[0055] If the control mortality rate is less than 5%, no correction is required; if the control mortality rate is between 5% and 15%, the corrected mortality rate should be calculated according to the formula; if the control mortality rate is greater than 15%, the test needs to be repeated.

[0056] Table 1

[0057]

[0058]

[0059]

[0060] According to the test, the indoor LC50 value of avermectin benzoate against root-knot nematodes is 3.59 mg / L, which is much lower than the activity of avermectin B synthesized by the present invention. 2a and their salt compounds.

[0061] 6. Conclusion

[0062] From the above experiments, we can see that:

[0063] 1. At a concentration of 1.0 mg / L, all the tested agents showed good activity.

[0064] 2. When the concentration is low, the test agent is avermectin B 2a Methanesulfonate, Emamectin B 2a Sorbate, Emamectin B 2a Tartrate showed relatively good control effect, which was better than the control agents avermectin, fluopyram and thiazolyl. The control effect of other tested agents on root-knot nematodes was slightly lower than fluopyram and thiazolyl, and the control effect was equal to avermectin.

Claims

1. Emamectin B 2a Application of salt compounds, Features: For the prevention and treatment of plant root-knot nematodes, the structure of the avermectin B2a salt compound is shown in Formula I: Where X - The acid anion is an acid anion derived from methanesulfonic acid, sorbic acid, or tartaric acid.

2. Emamectin B 2a Application of salt compounds, Features: Used for preparing pesticides for controlling plant root-knot nematodes.

3. Emamectin B according to claim 1 2a Application of salt compounds, Features: Emamectin B 2a The preparation method of the salt compound is as follows: avermectin B is reacted in a solvent 2a After dissolving and clarifying, add the corresponding acid, control the temperature below 40°C, stir for 30 minutes, and concentrate under reduced pressure to obtain the corresponding avermectin B 2a Salt.

4. Emamectin B according to claim 3 2a Application of salt compounds, Features: The dosage of methanesulfonic acid and sorbic acid and avermectin B 2a The molar ratio is 1:1; the amount of tartaric acid and avermectin B 2a The molar ratio is 0.5:

1.

5. Emamectin B according to claim 3 2a Application of salt compounds, Features: Emamectin B 2a The content is greater than 90%, and the amount of solvent used is the same as that of avermectin B 2a The weight ratio is 4:1 to 10:

1.

6. Emamectin B according to claim 3 2a Application of salt compounds, Features: The solvent is selected from one of methanol, ethanol, dichloromethane, dichloroethane, sec-butyl acetate and isopropyl acetate.

Citation Information

Patent Citations

  • Preparation method of methylamino abamectin B2 benzoate

    CN106995476A

  • Emamectin B2a / B2b benzoate emulsion and preparation method thereof

    CN109197882A

  • Avermectin B2a phosphorylation modifier as well as preparation method and application thereof

    CN109762015A